Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Furber

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Bioorganic & Medicinal Chemistry Letters|November 3, 2012
Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H₁ antagonists. Part II: optimising in vivo clearanceMark Furber, Lilian Alcaraz, Christopher Luckhurst, et al.
Plos Neglected Tropical Diseases|February 22, 2017
Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitorsAntonio C B Burtoloso, Sérgio de Albuquerque, Mark Furber, et al.
Journal of Medicinal Chemistry|March 6, 2014
Cathepsin C inhibitors: property optimization and identification of a clinical candidateMark Furber, Anna-Karin Tiden, Philip Gardiner, et al.
Journal of Medicinal Chemistry|October 30, 2007
Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitorsMark Furber, Lilian Alcaraz, Janice E Bent, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Bioorganic & Medicinal Chemistry Letters|November 3, 2012
Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H₁ antagonists. Part II: optimising in vivo clearanceMark Furber, Lilian Alcaraz, Christopher Luckhurst, et al.
Plos Neglected Tropical Diseases|February 22, 2017
Anti-trypanosomal activity of non-peptidic nitrile-based cysteine protease inhibitorsAntonio C B Burtoloso, Sérgio de Albuquerque, Mark Furber, et al.
Journal of Medicinal Chemistry|March 6, 2014
Cathepsin C inhibitors: property optimization and identification of a clinical candidateMark Furber, Anna-Karin Tiden, Philip Gardiner, et al.
Journal of Medicinal Chemistry|October 30, 2007
Discovery of potent and selective adamantane-based small-molecule P2X(7) receptor antagonists/interleukin-1beta inhibitorsMark Furber, Lilian Alcaraz, Janice E Bent, et al.
Pageof 2